PRISCO, DOMENICO
PRISCO, DOMENICO
Medicina Sperimentale e Clinica
"In Less than No Time": Feasibility of Rotational Thromboelastometry to Detect Anticoagulant Drugs Activity and to Guide Reversal Therapy
2022 Pavoni, Vittorio; Gianesello, Lara; Conti, Duccio; Ballo, Piercarlo; Dattolo, Pietro; Prisco, Domenico; Görlinger, Klaus
135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS
2019 Emmi, Giacomo; Bettiol, Alessandra; Urban, Maria Letizia; Sinico, Renato; Schiavon, Franco; Caporali, Roberto; Prisco, Domenico; Vaglio, Augusto
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
2023 Turpie, Alexander G G; Farjat, Alfredo E; Haas, Sylvia; Ageno, Walter; Weitz, Jeffrey I; Goldhaber, Samuel Z; Goto, Shinya; Angchaisuksiri, Pantep; Kayani, Gloria; Lopes, Renato D; Chiang, Chern-En; Gibbs, Harry; Tse, Eric; Verhamme, Peter; Ten Cate, Hugo; Muntaner, Juan; Schellong, Sebastian; Bounameaux, Henri; Prandoni, Paolo; Maheshwari, Uma; Kakkar, Ajay K; Prisco, Domenico
[Characteristics and clinical use of rivaroxaban for the treatment of atrial fibrillation and venous thromboembolism]
2014 Imberti, Davide; Agnelli, Giancarlo; Andreotti, Felicita; Dentali, Francesco; Gensini, Gian Franco; Landolfi, Raffaele; Micieli, Giuseppe; Prisco, Domenico
A double-edged sword: e-cigarettes, and other electronic nicotine delivery systems (ENDS): reply
2020 Polosa R.; Farsalinos K.; Prisco D.
A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management
2018 Prisco, Domenico
A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion.
2012 Cellai AP;Lami D;Fedi S;Marcucci R;Mannini L;Cenci C;Rogolino A;Sodi A;Menchini U;Abbate R;Prisco D
A new case of idiopathic recurrent acute pericarditis due to R104Q mutation in TNFRSF1A successfully treated with anakinra: expanding the questions
2014 Emmi, G; Barnini, T; Silvestri, E; Milco D'Elios, M; Emmi, L; Prisco, D
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies
2015 Niccolai, Elena; Squatrito, Danilo; Emmi, Giacomo; Silvestri, Elena; Emmi, Lorenzo; Ciucciarelli, Lucia; Ricci, Federica; Manganaro, Daniele; Amedei, Amedeo; Prisco, Domenico
A severe case of warfarin-canrenoate interaction: a role for genetic predisposition?
2010 V. Maggini; A. Pugi; D. Coletta; M. Vietri; B. Giusti; D. Prisco; A. Mugelli; F. Lapi; A. Vannacci
A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome
2021 Emmi, Giacomo; Bagni, Giacomo; Lastraioli, Elena; Di Patti, Francesca; Bettiol, Alessandra; Fiorillo, Claudia; Becatti, Matteo; Silvestri, Elena; Urban, Maria Letizia; Emmi, Lorenzo; Prisco, Domenico; Arcangeli, Annarosa
Ability of whole blood aggregometer to detect platelet hyperaggregability
1989 R.Abbate; M.Boddi; D.Prisco; GF.Gensini
Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina
1985 GG.Neri Serneri; GF.Gensini; R.Abbate; D.Prisco; PG.Rogasi; R.Laureano; GC.Casolo; F.Fantini; M.Di Donato; RP.Dabizzi
ACE DD genotype: an independent predisposition factor to venous thromboembolism.
2003 FATINI C; GENSINI F; STICCHI E; BATTAGLINI B; PRISCO D; FEDI S; BRUNELLI T; MARCUCCI R; A. CONTI; GENSINI GF; ABBATE R
Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII:c levels.
1999 Marcucci R; Abbate R; Fedi S; Gori AM; Brunelli T; Bruni V; Bucciantini S; Micheli S; Pepe G; Prisco D; Gensini GF.
Acquired hemophilia A: a rare but important challenge for the internist
2005 D.Prisco
Activated protein C resistance is a risk factor for central retinal vein occlusion
2000 R.Marcucci; L.Bertini; A.Alessandrello Liotta; A.Rogolino; E.Antonucci; I.Ilari; G.Pepe; D.Prisco
Activation of the coagulation system during electrophysiologic invasive study with and without ablation
1997 A. Michelucci; L. Padeletti; E. Antonucci; A. A. Conti; A. A. Liotta; S. Fedi; D. Prisco; R. Abbate; G. F. Gensini
Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies.
2001 A. FARSI; T. BRUNELLI; A. GORI; S. FEDI; GF. GENSINI; D. PRISCO; A. PASSALEVA; R. ABBATE; M. DOMENEGHETTI; C. GIGLIOLI; P. MERONI; N. DEL PAPA
Acute coronary syndromes with significant troponin increase in patients with hip fracture prior to surgical repair: differential diagnosis and clinical implications
2015 Rostagno C, Cammilli A, Di Cristo A, Polidori GL, Ranalli C, Cartei A, Buzzi R, Prisco D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "In Less than No Time": Feasibility of Rotational Thromboelastometry to Detect Anticoagulant Drugs Activity and to Guide Reversal Therapy | 2022 | Pavoni, Vittorio; Gianesello, Lara; Conti, Duccio; Ballo, Piercarlo; Dattolo, Pietro; Prisco, Domenico; Görlinger, Klaus | |
| 135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS | 2019 | Emmi, Giacomo; Bettiol, Alessandra; Urban, Maria Letizia; Sinico, Renato; Schiavon, Franco; Caporali, Roberto; Prisco, Domenico; Vaglio, Augusto | |
| 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE | 2023 | Turpie, Alexander G G; Farjat, Alfredo E; Haas, Sylvia; Ageno, Walter; Weitz, Jeffrey I; Goldhaber, Samuel Z; Goto, Shinya; Angchaisuksiri, Pantep; Kayani, Gloria; Lopes, Renato D; Chiang, Chern-En; Gibbs, Harry; Tse, Eric; Verhamme, Peter; Ten Cate, Hugo; Muntaner, Juan; Schellong, Sebastian; Bounameaux, Henri; Prandoni, Paolo; Maheshwari, Uma; Kakkar, Ajay K; Prisco, Domenico | |
| [Characteristics and clinical use of rivaroxaban for the treatment of atrial fibrillation and venous thromboembolism] | 2014 | Imberti, Davide; Agnelli, Giancarlo; Andreotti, Felicita; Dentali, Francesco; Gensini, Gian Franco; Landolfi, Raffaele; Micieli, Giuseppe; Prisco, Domenico | |
| A double-edged sword: e-cigarettes, and other electronic nicotine delivery systems (ENDS): reply | 2020 | Polosa R.; Farsalinos K.; Prisco D. | |
| A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management | 2018 | Prisco, Domenico | |
| A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion. | 2012 | Cellai AP;Lami D;Fedi S;Marcucci R;Mannini L;Cenci C;Rogolino A;Sodi A;Menchini U;Abbate R;Prisco D | |
| A new case of idiopathic recurrent acute pericarditis due to R104Q mutation in TNFRSF1A successfully treated with anakinra: expanding the questions | 2014 | Emmi, G; Barnini, T; Silvestri, E; Milco D'Elios, M; Emmi, L; Prisco, D | |
| A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies | 2015 | Niccolai, Elena; Squatrito, Danilo; Emmi, Giacomo; Silvestri, Elena; Emmi, Lorenzo; Ciucciarelli, Lucia; Ricci, Federica; Manganaro, Daniele; Amedei, Amedeo; Prisco, Domenico | |
| A severe case of warfarin-canrenoate interaction: a role for genetic predisposition? | 2010 | V. Maggini; A. Pugi; D. Coletta; M. Vietri; B. Giusti; D. Prisco; A. Mugelli; F. Lapi; A. Vannacci | |
| A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome | 2021 | Emmi, Giacomo; Bagni, Giacomo; Lastraioli, Elena; Di Patti, Francesca; Bettiol, Alessandra; Fiorillo, Claudia; Becatti, Matteo; Silvestri, Elena; Urban, Maria Letizia; Emmi, Lorenzo; Prisco, Domenico; Arcangeli, Annarosa | |
| Ability of whole blood aggregometer to detect platelet hyperaggregability | 1989 | R.Abbate; M.Boddi; D.Prisco; GF.Gensini | |
| Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina | 1985 | GG.Neri Serneri; GF.Gensini; R.Abbate; D.Prisco; PG.Rogasi; R.Laureano; GC.Casolo; F.Fantini; M.Di Donato; RP.Dabizzi | |
| ACE DD genotype: an independent predisposition factor to venous thromboembolism. | 2003 | FATINI C; GENSINI F; STICCHI E; BATTAGLINI B; PRISCO D; FEDI S; BRUNELLI T; MARCUCCI R; A. CONTI; GENSINI GF; ABBATE R | |
| Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII:c levels. | 1999 | Marcucci R; Abbate R; Fedi S; Gori AM; Brunelli T; Bruni V; Bucciantini S; Micheli S; Pepe G; Prisco D; Gensini GF. | |
| Acquired hemophilia A: a rare but important challenge for the internist | 2005 | D.Prisco | |
| Activated protein C resistance is a risk factor for central retinal vein occlusion | 2000 | R.Marcucci; L.Bertini; A.Alessandrello Liotta; A.Rogolino; E.Antonucci; I.Ilari; G.Pepe; D.Prisco | |
| Activation of the coagulation system during electrophysiologic invasive study with and without ablation | 1997 | A. Michelucci; L. Padeletti; E. Antonucci; A. A. Conti; A. A. Liotta; S. Fedi; D. Prisco; R. Abbate; G. F. Gensini | |
| Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies. | 2001 | A. FARSI; T. BRUNELLI; A. GORI; S. FEDI; GF. GENSINI; D. PRISCO; A. PASSALEVA; R. ABBATE; M. DOMENEGHETTI; C. GIGLIOLI; P. MERONI; N. DEL PAPA | |
| Acute coronary syndromes with significant troponin increase in patients with hip fracture prior to surgical repair: differential diagnosis and clinical implications | 2015 | Rostagno C, Cammilli A, Di Cristo A, Polidori GL, Ranalli C, Cartei A, Buzzi R, Prisco D. |